<- Go Home
GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Market Cap
$1.2B
Volume
794.9K
Cash and Equivalents
$93.9M
EBITDA
-$7.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$307.9M
Profit Margin
69.56%
52 Week High
$170.87
52 Week Low
$32.21
Dividend
N/A
Price / Book Value
4.62
Price / Earnings
-14.73
Price / Tangible Book Value
10.93
Enterprise Value
$1.2B
Enterprise Value / EBITDA
2.5K
Operating Income
-$33.3M
Return on Equity
30.42%
Return on Assets
-4.37
Cash and Short Term Investments
$170.7M
Debt
$168.2M
Equity
$254.1M
Revenue
$442.7M
Unlevered FCF
$5.3M
Sector
Health Care Providers and Services
Category
N/A